FLT3LG and cancer: Given the great variability in the susceptibility of different cancer cell lines to oHSV1-FLT3L-mediated growth inhibition, we sought to determine whether factors such as the expression of viral entry receptors, antiviral machinery genes, or mutational status influenced their sensitivity.